Catalyst Wire Dossier Catalyst Wire Dossier

Survodutide

BI456906 · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for Survodutide, covering 2024-12-03 to 2026-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) [Phase 3]

See pricing